Evidence map›Paper›PMID 38078770›Full record

ArticlemBio2024

Comparative evolution of influenza A virus H1 and H3 head and stalk domains across host species.

Nidia S Trovão, Sairah M Khan, Philippe Lemey, Martha I Nelson, Joshua L Cherry

Abstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nidia S TrovãoFogarty International Center, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-2106-1166
Sairah M KhanFogarty International Center, National Institutes of Health, Bethesda, Maryland, USA.
Philippe LemeyDepartment of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
Martha I NelsonFogarty International Center, National Institutes of Health, Bethesda, Maryland, USA.
Joshua L CherryFogarty International Center, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0002-4076-1862

Funding

Technology CoreU19AI135995 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI Bryan Briney · 2018 to 2026
$32.0M
Phase II - Development of a Prophylactic Onchocerciasis Vaccine75N93019C00028 · NIAID · PAI LIFE SCIENCES, INC. · PI CARTER, DARRICK · 2019 to 2019
$3.0M
Statistical Innovation to Integrate Sequences and Phenotypes for Scalable Phylodynamic InferenceR01AI153044 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Marc A. Suchard · 2021 to 2026
$2.4M
Phylodynamics of emerging infectious disease threatsZIALM010027 · NLM · NATIONAL LIBRARY OF MEDICINE · PI NELSON, MARTHA · 2024 to 2025
$1.5M
NIAID NIH HHS 75N93019C00028NIAID NIH HHS HHSN272201400008CNIAID NIH HHS R01 AI153044NIAID NIH HHS U19 AI135995Wellcome Trust
6 · The paper itself

Abstract

importanceFor decades, researchers have studied the rapid evolution of influenza A viruses for vaccine design and as a useful model system for the study of host/parasite evolution. By performing an exhaustive analysis of hemagglutinin protein (HA) sequences from 49 lineages independently evolving in birds, swine, canines, equines, and humans over the last century, our work uncovers surprising features of HA evolution. In particular, the canine H3 stalk, unlike human H3 and H1 stalk domains, is not evolving slowly, suggesting that evolution in the stalk domain is not universally constrained across all host species. Therefore, a broader multi-host perspective on HA evolution may be useful during the evaluation and design of stalk-targeted vaccine candidates.

Indexed as

Influenza A virusInfluenza, HumanInfluenza VaccinesOrthomyxoviridae InfectionsVaccinesAnimalsAntibodies, ViralDogsHemagglutinin Glycoproteins, Influenza VirusHemagglutininsHorsesHost SpecificityHumansSwineAntibodies, ViralHemagglutinin Glycoproteins, Influenza VirusHemagglutininsInfluenza VaccinesVaccinesadaptive evolutionglycosylationhemagglutinininfluenza A virusinter-species transmissionphylodynamics

Identifiers

PMID38078770
PMCPMC10886446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.